International Archives of Allergy and Immunology
Guidelines for Authors
Aims & Scopes
International Archives of Allergy and Immunology provides a forum for experimental and clinical research in allergy and immunology. Appearing monthly, the journal publishes original work in the fields of allergy, immunopathology, immunogenetics, immunopharmacology, immunoendocrinology, tumor immunology, mucosal immunity, transplantation and immunology of infectious and connective tissue diseases. In addition to research articles it features brief reports, reviews, mini reviews, commentaries and opinion papers. A team of internationally renowned and committed editors guarantees a fair review process, high scientific quality and fast dissemination of significant and novel work.
In addition to the standard Article Types, we also invite contributions to the following sections:
Position Papers are considered as one side of an arguable opinion about an ongoing scientific dispute. The goal of a Position Paper is to convince the audience that the opinion of the authors is valid and defensible. It is very important that all sides of the issue are addressed and presented it in a manner that is easy to understand for the scientific community.
Authors of a Position Paper need to take one side of the argument, which has to be supported with evidence to ensure the validity of your claims. The counterclaims also need to be presented to demonstrate that authors are informed about other perspectives. Position Papers are usually invited by the editors but may be unsolicited. Manuscripts should be submitted under the Article Type "Other Types"; potential authors should contact the Editor-in-Chief before submission.
The Journal no longer considers Case Reports for publication.
Should you have any problems with your submission, please contact the editorial office:
Editorial Office International Archives of Allergy and Immunology
S. Karger AG
CH-4009 Basel (Switzerland)
Tel. +41 61 306 1357
Fax +41 61 306 1434
Only papers written in English are considered. The articles should be comprehensible to a reader who is fluent in English and should be edited prior to submission to ensure that standard English grammar and usage are observed. Use of a professional language editing service prior to submission can help avoid delays with the review process.
All manuscripts are subject to editorial review.
The presentation of manuscripts should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals from the International Committee of Medical Journal Editors (ICMJE).
Karger journals adhere to the COPE Code of Conduct and Best Practice Guidelines.
By submitting an article for publication, the authors agree to the transfer of the copyright to the publisher upon acceptance. Accepted papers become the permanent property of International Archives of Allergy and Immunology and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.
The Submission Statement with original (hand-written) signatures is to be provided upon submitting the paper. If it is not possible to collect all signatures on a single document, individual copies should be provided for each author. Manuscripts may be accompanied by a cover letter in addition to the Submission Statement if additional information is to be communicated to the Editor(s)-in-Chief.
It is the authors’ responsibility to obtain permission to reproduce illustrations, tables, etc., from other publications.
All submitted manuscripts must contain a Statement of Ethics and a Disclosure Statement after the main body of the text, but before the reference list. More information on statements can be found in the article samples downloadable in the Article Types section.
Whether intentional or not, plagiarism is a serious offense. If evidence of plagiarism is found before or after acceptance, or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are found to be unsatisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).
For reports of epidemiological studies, authors should consult the STROBE initiative.
Authors of trials should adhere to the CONSORT reporting guidelines appropriate to their trial design. Authors of genetic association studies are strongly encouraged to consult the recommendations issued by the STREGA initiative. Reports of microarray experiments should conform to the MIAME guidelines, in an appropriate publicly accessible database. Manuscripts dealing with recombinant allergens will only be considered for external review if they:
- describe a new allergen or a class of new allergenic molecules; ii) show the clinical relevance of the allergens;
- describe new technological approaches for cloning, production and/or characterization of allergens; the sequence has been submitted, accepted and assigned with an official name by the I.U.I.S. Allergen
- Nomenclature Sub-committee provides a relevant progress with respect to the state of the art of the research in the field of molecular allergy; manuscripts, which do not fulfil the requirements, but which contain interesting information of potential interest for the readers of Allergy, might be considered for publication as a short communication.
International Archives of Allergy and Immunology is a peer-reviewed journal that uses a single-blind peer review system. Our aim is to provide
authors with timely and constructive feedback regarding their submitted manuscript. The Editor(s)-in-Chief and the
international editorial board ensure a thorough and fair peer review process and the highest scientific publishing
standards. Editors guide the peer review process for papers in their areas of expertise.
Reviewers must have a recent publication record in the area of the submitted
paper, must not have published with the authors in the previous three years, and must not be from the same
institut¡on as the authors.
The Editor(s)-in-Chief is/are responsible for maintaining a high-quality peer review of papers submitted to the journal. Their decision concerning the acceptance or rejection of submitted manuscripts is final.
A sample can be downloaded here.
Brief Reports are short and/or rapid announcements of research results. They must contain data derived from cutting-edge research and be of potential interest to a large proportion of the readership. They are independent, concise reports representing a significant contribution to the field. Such communications should represent complete, original studies and should be arranged in the same way as full-length manuscripts except that the separate sections should not be formally titled.
Manuscripts intended for publication as Brief Reports must present new findings of sufficient importance to justify their accelerated acceptance.
Word count: Should not contain more than 5 manuscript pages, including an abstract, essential references and not more than 3 tables or figures.
A sample can be downloaded here.
A discussion related to a specific article or issue written by an editor or other publication staff
A sample can be downloaded here.
Letters are encouraged if they directly concern articles recently published in the journal. If accepted, the editors reserve the right to submit such letters to the authors of the articles concerned prior to publication, in order to permit them to respond in the same issue of the journal.
In exceptional cases, Letters may also address data published in another journal or general subjects related to matters discussed in the journal.
Word Count: Should not exceed 2 manuscript pages including one table or figure.
A sample can be downloaded here.
Research Articles report on primary research. They should represent original research in basic, translational, or clinical science. They must describe significant and original observations. Consideration for publication is based on the article’s originality, novelty, and scientific soundness, and the appropriateness of its analysis. Research Articles are reports of original work (including systematic reviews and meta-analyses). Authors are asked to follow the CONSORT guidelines for Research Articles. Prior approval from an Institutional Review Board (IRB) or an Ethics Review Committee is required for all investigations involving human subjects.
A sample can be downloaded here.
Review Articles are considered reviews of research or summary articles. They are state-of-the-art papers covering a current topic by experts in the field. They should give evidence on and provide answers to a well-defined aspect or question in a particular area. Review Articles must include a critical discussion of the reported data and give a clear conclusion with potential impacts on the standard of care.
Review Articles are usually invited by the editors but may be unsolicited. Potential authors are asked to contact the editorial office before submission in order to avoid clashes with other pending reviews.
The preferred word processing program for manuscripts is Microsoft Word. Page and line numbering should be activated, and subtitles within the document should be numbered for clarity. Footnotes should be avoided. When essential, they should be numbered consecutively and appear at the foot of the appropriate page. Abbreviations (with the exception of those clearly well established in the field) should be explained when they are first used both in the abstract and in the main text. Units of measurement should be expressed in SI units wherever possible. Generic names of drugs (first letter: lowercase) should be used whenever possible. Registered trade names (first letter: uppercase) should be marked with the superscript registration symbol ® or ™ when they are first mentioned. The manuscript, tables, figures, and submission statement must be submitted in separate files. For further technical specifications, including those regarding tables, figures, and illustrations, please refer to the Karger website
The first page should contain a short and concise title plus a running head of no more than 80 characters.
Abbreviations should be avoided.
Below the title, list all the authors’ names as outlined in the article sample, which can be downloaded under Article Types.
Each listed author must have an affiliation, which comprises the department, university, or organization and its location, city, state/province (if applicable), and country.
Place the full postal address of the corresponding author at the bottom of the first page, including at least one telephone number and e-mail address.
Keywords relevant to the article should be listed below the corresponding author information.
Please refer to the Article Types section of the Guidelines for Authors for information on the relevant article structure, including maximum word counts and downloadable samples.
Supplementary files may be used to enhance a publication and increase its visibility on the Web. Supplementary files (directly relevant but not essential to the conclusions of the paper) will undergo editorial review and should be submitted in a separate file with the original manuscript and with all subsequent submissions. The editors reserve the right to limit the scope and length of supplementary material. Supplementary material must meet production quality standards for publication without the need for any modification or editing and should not exceed 10 Mb in size. Figures and tables must have titles and legends, and all files must be supplied separately and named clearly. Acceptable files and formats are Word or PDF files, Excel spreadsheets (if the data cannot be converted properly into a PDF file), and multimedia files (MPEG, AVI, or QuickTime formats). All supplementary material should be referred to in the main text. A DOI number will be assigned to supplementary material, and it will be hosted online at www.karger.figshare.com under a CC BY license.
References in the text should be identified using Arabic numerals [in square brackets]. The reference list should not be alphabetized, but the references should be numbered consecutively in the order in which they are first mentioned in the text. Material submitted for publication but not yet accepted should be noted as ‘unpublished data’ and may not be included in the reference list.
Reference Management Software
The use of EndNote is recommended to facilitate formatting of citations and reference lists. The journal output style can be downloaded from the EndNote website.
Karger Publishers offers a range of services to assist authors with the preparation of their manuscript, including
discounts for language editing services offered by third parties.
More information is available on the Author Resources section of the Karger homepage. A guide to scientific
publishing can also be downloaded here.
When submitting a manuscript, authors can add their ORCID number to their Karger account to ensure that their paper is accredited to them correctly.
Cost of Publication
Please note that adherence to word limits indicated in previous paragraphs does not guarantee excemption from
APCs or page charges. Charges are calculated purely on the final page count of the accepted and edited article.
Page charges vary depending on the number of pages of the article. See below for more information about price points and page allowances.
Number of free Pages: 5
Standard charge per page: Each additional complete or partial page is charged to the author at CHF 325.00.
Authors will be charged a processing fee for hosting supplementary material.
Fee for Online Supplementary Materials: CHF 250.00
Online edition: Color illustrations are reproduced free of charge. In the print version, the illustrations are
reproduced in grayscale. Please avoid referring to colors in the text and figure legends.
Print edition: Up to 6 color illustrations per page can be integrated within the text at CHF 960.00 per page.
Karger Publisher’s Author’s Choice™ service broadens the reach of your article and gives all users worldwide free
and full access for reading, downloading, and printing at www.karger.com. The option is available for a one-time
fee, which is a permissible cost in grant allocation. More information can be found at www.karger.com/authors_choice.
The final, published version of the article may be posted at any time and in any repository or on other websites, in accordance with the relevant Creative Commons license as well as the current Karger self-archiving policy for Open Access articles. Karger supplies all articles to PubMed Central for indexing.
Fee for Author's Choice: CHF 3,000.00
Journal Journal Policies
Manuscripts accepted for publication by Karger Publishers are subject to copyediting. Karger Publishers’ house style is based on internationally recognized standard manuals, including The Chicago Manual of Style.
An email containing a link to download the PDF proofs will be sent to the corresponding author.
The authors should check the PDF document and respond to any questions that have been raised during proofreading within 48 hours.
Alterations made to proofs, other than the correction of errors introduced by the Publisher, are charged to the authors and may require editorial approval.
Please note that the revised proofs are not sent to the authors prior to typesetting and online publication unless there are exceptional circumstances. The article layout will be created according to the Karger standard.
A DOI number will be available as a unique identifier on the title page of each article. DOIs are useful for identifying and citing articles published online without volume or issue information (for more information, see www.doi.org).
All articles are published electronically with a DOI number as soon as we have received the authors’ approval to print.
The Submission Statement outlines the licensing and copyright terms. A copy of the Submission Statement originally hand signed by all authors must be received by the editorial office. Please print and sign the form, and upload it during submission to make it legally binding. A brief cover letter may also be included if additional information is to be communicated to the Editor(s)-in-Chief.
Karger permits authors to archive their preprints (i.e., before peer review) or postprints (i.e., accepted manuscripts after peer review but before production) on their personal home page or institution’s repository, provided that
these are not used for commercial purposes, are linked to the publisher’s version, and acknowledge the publisher’s
In addition, authors may post their accepted manuscripts in public Open Access repositories and scientific networks (e.g., ResearchGate or Mendeley) no earlier than 12 months following publication of the final version of their article. For all self-archiving, the posted manuscripts must:
- Be used for noncommercial purposes only
- Be linked to the final version on www.karger.com and include the following statement:
‘This is the peer-reviewed but unedited manuscript version of the following article: [insert full citation, e.g., Cytogenet Genome Res 2014;142:227–238 (DOI: 10.1159/000361001)]. The final, published version is available at http://www.karger.com/?doi=[insert DOI number].’
It is the author’s responsibility to fulfill these requirements.
For papers published online first with a DOI number only, full citation details must be added as soon as the paper is published in its final version. This is important to ensure that citations can be credited to the article. Manuscripts to be archived in PubMed Central due to funding requirements or that have been published under the Author’s Choice™ scheme will be submitted by Karger on the authors’ behalf, as outlined under Funding Organizations.
If the authors are affiliated with an organization that has an offsetting agreement with Karger Publishers which may allow them to publish their article free of charge, this should be communicated in a cover letter at the submission stage, so that eligibility can be assessed.
The US National Institutes of Health (NIH) Public Access Policy mandates that final, peer-reviewed manuscripts are archived in its digital database PubMed Central (PMC) within 12 months of the official publication date. As a service to authors, Karger Publishers submits the final, published version of Open Access NIH-funded manuscripts to PMC upon publication. The final, peer-reviewed article is made available after a 12-month embargo period. Where the authors have chosen to make their paper freely available under Karger’s Author’s Choice™ service, this embargo does not apply.
Other Funding Sources
Karger Publishers also complies with other funders’ requirements (including the Wellcome Trust and RCUK) for
submission to PMC. Authors should include information on their grants in the Funding Sources section of their
More information on funding sources can be found on the Karger website.
Manuscripts should be submitted online via the submission portal.
Before submission, please read the Guidelines for Authors for specific requirements for manuscript preparation.
A Submission Statement signed by all authors must be received by the editorial office. Please print and sign the form, and upload it during submission to make it legally binding. A brief cover letter outlining in how far the work is interdisciplinary and what is new in regard to the current literature on the topic may be included, but this is not essential.